A Tapan Ray Website
With Shri P. H. Kurian, Patents Controller General of India - 1 (2)
With FDA Commissioner, Maharashtra – 1
With Dr. A. K. Banerjee, NPPA Chairman – 2
With Dr. A. K. Banerjee, NPPA Chairman – 1
With Dr. Ajit Dangi
With Dominic Keating of USPTO, US Embassy, New Delhi
Convocation at IIPS of NMIMS University, Mumbai
Convocation at IIPS of NMIMS University, Mumbai
Addressing OPPI Anti-Counterfeiting Seminar - July 3, 2009, Mumbai
With IPR experts and Managing Directors of Pharma Companies
With IPR experts
With Prof. Shamnad Basheer
With the CEO of MHRA, UK
With the CEO of MHRA, UK
With the CEO of MHRA, UK
With the Managing Directors of Pharmaceutical Companies in India and KPMG Partner
With the Managing Directors of Pharmaceutical Companies in India
With the Managing Directors of Pharmaceutical Companies in India
Release of OPPI Annual report by the Secretary Mr. Ashok Kumar of the Department of Pharmaceuticals, Government of India
Release of OPPI- Yes Bank report by the Secretary Mr. Ashok Kumar of the Department of Pharmaceuticals, Government of India
With Shri P. H. Kurian, Patents Controller General of India - 1 (2)
With FDA Commissioner, Maharashtra – 1
With Dr. A. K. Banerjee, NPPA Chairman – 2
With Dr. A. K. Banerjee, NPPA Chairman – 1
With Dr. Ajit Dangi
With Dominic Keating of USPTO, US Embassy, New Delhi
Convocation at IIPS of NMIMS University, Mumbai
Convocation at IIPS of NMIMS University, Mumbai
Addressing OPPI Anti-Counterfeiting Seminar - July 3, 2009, Mumbai
With IPR experts and Managing Directors of Pharma Companies
With IPR experts
With Prof. Shamnad Basheer
With the CEO of MHRA, UK
With the CEO of MHRA, UK
With the CEO of MHRA, UK
With the Managing Directors of Pharmaceutical Companies in India and KPMG Partner
With the Managing Directors of Pharmaceutical Companies in India
With the Managing Directors of Pharmaceutical Companies in India
Release of OPPI Annual report by the Secretary Mr. Ashok Kumar of the Department of Pharmaceuticals, Government of India
Release of OPPI- Yes Bank report by the Secretary Mr. Ashok Kumar of the Department of Pharmaceuticals, Government of India